Title : Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers.

Pub. Date : 2007 Apr

PMID : 17379017






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pioglitazone, but not voglibose, reduced CRP levels within 1 month (-51%+/-7%, mean+/-SEM; P<.001). Pioglitazone C-reactive protein Homo sapiens
2 C-reactive protein levels were decreased after 6 months of treatment with either pioglitazone or voglibose, with the former being more effective (-57%+/-8% vs -9%+/-18%; P<.05). Pioglitazone C-reactive protein Homo sapiens